CIMTYVIST Trademark

Trademark Overview

On Monday, August 29, 2022, a trademark application was filed for CIMTYVIST with the United States Patent and Trademark Office. The USPTO has given the CIMTYVIST trademark a serial number of 97568661. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 18, 2024. This trademark is owned by Bayer Aktiengesellschaft. The CIMTYVIST trademark is filed in the Pharmaceutical Products category with the following description:

Contrast media for use in medical imaging
cimtyvist

General Information

Serial Number97568661
Word MarkCIMTYVIST
Filing DateMonday, August 29, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Goods and ServicesContrast media for use in medical imaging

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE

Trademark Events

Event DateEvent Description
Thursday, September 1, 2022NEW APPLICATION ENTERED
Thursday, September 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 14, 2023ASSIGNED TO EXAMINER
Wednesday, June 14, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 14, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 12, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, October 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 14, 2024ASSIGNED TO LIE
Thursday, March 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, March 18, 2024EXAMINERS AMENDMENT E-MAILED
Monday, March 18, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 18, 2024EXAMINER'S AMENDMENT ENTERED
Monday, March 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2024TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

cimtyvist imaging medical media contrast